$1.54 -0.03 (-1.93%)
Jupiter Neurosciences, Inc. Common Stock (JUNS)
Jupiter Neurosciences, Inc. (JUNS) is a biopharmaceutical company focused on developing treatments for neurological and psychiatric disorders. The company specializes in advancing innovative therapies targeting unmet medical needs in the field of brain health.
Company News
Jupiter Neurosciences Highlights Critical Advancement of JOTROLâ„¢ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science
Jupiter Neurosciences announced a significant advancement in resveratrol technology with JOTROLâ„¢, achieving nine-fold increased bioavailability and reduced gastrointestinal side effects, with potential applications in neurodegenerative disease treatment and consumer supplements.